Go Pro
NASDAQ:HCAT

Health Catalyst (HCAT) Stock Price, News & Analysis

Health Catalyst logo
$1.75 -0.04 (-2.23%)
Closing price 08/13/2026 04:00 PM Eastern
Extended Trading
$1.78 +0.02 (+1.43%)
As of 04:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Health Catalyst Stock (NASDAQ:HCAT)

Advanced

Key Stats

Today's Range
$1.73
$1.86
50-Day Range
$1.60
$2.39
52-Week Range
$0.96
$3.80
Volume
1.52 million shs
Average Volume
888,089 shs
Market Capitalization
$131.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.93
Consensus Rating
Hold

Company Overview

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment. Built on cloud-native architecture, DOS provides analytics applications and tools for care management, performance improvement, population health and financial analysis.

In addition to its platform technology, Health Catalyst provides professional services including implementation support, data engineering, performance improvement consulting and change management. These services are designed to help health systems and hospitals accelerate adoption of data-driven practices, improve clinical quality and reduce costs through evidence-based interventions.

Health Catalyst serves more than 450 healthcare organizations across the United States and has expanded its footprint into select international markets. The company is led by an executive team with deep experience in health IT and population health, and it partners with clients ranging from community hospitals to large integrated health systems to drive measurable improvements in patient outcomes and operational efficiency.

AI Generated. May Contain Errors.

Health Catalyst Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
73rd Percentile Overall Score

HCAT MarketRank™: 

Health Catalyst scored higher than 73% of companies evaluated by MarketBeat, and ranked 189th out of 911 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Health Catalyst has received a consensus rating of Hold. The company's average rating score is 2.23, and is based on no strong buy ratings, 4 buy ratings, 8 hold ratings, and 1 sell rating.

  • Upside Potential

    Health Catalyst has a consensus price target of $2.93, representing about 67.5% upside from its current price of $1.75.

  • Amount of Analyst Coverage

    Health Catalyst has only been the subject of 4 research reports in the past 90 days.

  • Read more about Health Catalyst's stock forecast and price target.
  • Earnings Growth

    Earnings for Health Catalyst are expected to grow in the coming year, from ($0.25) to ($0.24) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Health Catalyst is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Health Catalyst is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Health Catalyst has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.92% of the float of Health Catalyst has been sold short.
  • Short Interest Ratio / Days to Cover

    Health Catalyst has a short interest ratio ("days to cover") of 6.06.
  • Change versus previous month

    Short interest in Health Catalyst has recently decreased by 18.08%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Health Catalyst does not currently pay a dividend.

  • Dividend Growth

    Health Catalyst does not have a long track record of dividend growth.

  • News Sentiment

    Health Catalyst has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for Health Catalyst this week, compared to 3 articles on an average week.
  • Search Interest

    Only 4 people have searched for HCAT on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Health Catalyst insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    19.40% of the stock of Health Catalyst is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Health Catalyst's insider trading history.
Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HCAT Stock News Headlines

Wall Street Preps for a 382 Trillion Dollar Financial Shift by 2027
Venture capital investment in US crypto companies hit $7.9 billion last year, up 44 percent from the year before, as the smartest institutional money doubles down on blockchain infrastructure. This isn't speculative crypto trading. It's the payment rails and settlement systems moving money faster and cheaper. BlackRock, JPMorgan, and Fidelity are already accumulating the single digital asset positioned at the center of a $382 trillion shift in financial assets by April 2027.tc pixel
See More Headlines

HCAT Stock Analysis - Frequently Asked Questions

Health Catalyst's stock was trading at $2.39 at the start of the year. Since then, HCAT stock has decreased by 26.8% and is now trading at $1.75.

Health Catalyst, Inc. (NASDAQ:HCAT) posted its earnings results on Thursday, August, 6th. The company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.01. The business had revenue of $70.49 million for the quarter, compared to analysts' expectations of $69.09 million. Health Catalyst had a negative trailing twelve-month return on equity of 1.57% and a negative net margin of 90.61%.
Read the conference call transcript
.

Health Catalyst (HCAT) raised $172 million in an IPO on Wednesday, July 24th 2019. The company issued 7,000,000 shares at $24.00-$25.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

Top institutional investors of Health Catalyst include BlackRock Inc. (2.49%), Bank of New York Mellon Corp (0.11%), Williams & Novak LLC (0.07%) and EP Wealth Advisors LLC (0.07%). Insiders that own company stock include Kevin Lee Freeman, Daniel Lesueur, Benjamin Landry, Jason Alger, Linda Llewelyn, Julie Larson-Green and Duncan Gallagher.
View institutional ownership trends
.

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Health Catalyst investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), Voyager Therapeutics (VYGR) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
8/06/2026
Today
8/14/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
NASDAQ:HCAT
CIK
1636422
Fax
N/A
Employees
1,200
Year Founded
2008

Price Target and Rating

High Price Target
$5.00
Low Price Target
$1.50
Potential Upside/Downside
+67.5%
Consensus Rating
Hold
Rating Score (0-4)
2.23
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.68)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$177.97 million
Net Margins
-90.61%
Pretax Margin
-87.39%
Return on Equity
-1.57%
Return on Assets
-0.75%

Debt

Debt-to-Equity Ratio
1.10
Current Ratio
1.69
Quick Ratio
1.69

Sales & Book Value

Annual Sales
$311.14 million
Price / Sales
0.42
Cash Flow
$2.08 per share
Price / Cash Flow
0.84
Book Value
$3.47 per share
Price / Book
0.50

Miscellaneous

Outstanding Shares
75,260,000
Free Float
60,656,000
Market Cap
$131.71 million
Optionable
Optionable
Beta
1.55

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:HCAT) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners